Hot Investor Mandate: Trans-Atlantic VC Firm Invests in USA & Europe Startups Developing Early-Stage Technologies Across Biotech and Medtech

16 May

The firm is a trans-Atlantic venture investment firm focused on building innovative Life Sciences businesses in the UK, Europe and the USA. The firm has a highly experienced team that focuses on turning break-through science into approved medicines or medical products.

The firm starts and invests in early and mid-stage companies with a first-in-class or best-in-class approach. The investments are focused in new drug discovery – small molecules, biologics and new modalities – med tech, enabling technologies and vaccines.

The firm’s team are well connected team and experienced, and the team supports each investment. The firm works in close alignment with management teams, and partners with them to realize their vision and achieve financial returns by bringing innovation to patients.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: